A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study. The research, published Friday in the Journal of the American College of Cardiology, found during a clinical trial of Wegovy that people taking the obesity drug during the COVID pandemic were less likely to die from the virus. Semaglutide,...
How Idaho's abortion ban limits reproductive care
- today, 4:00 PM
- abcnews.go.com
- 0

No comments